BioCentury
ARTICLE | Company News

Pernix Therapeutics sales and marketing update

January 30, 2012 8:00 AM UTC

Pernix gained exclusive, U.S. marketing rights to an undisclosed gastroenterology product recently approved by FDA from an undisclosed private company. The undisclosed company received $2 million up f...